FilingSEC EDGAR8-K
BioCardia Provides Update on Regulatory Submission Milestones
· SEC accepted
StageClinical/Regulatory
Filing content
BioCardia announced it is working toward a regulatory submission to Japan's PMDA in Q4 2026 and is preparing a De Novo pre-submission for its Helix system in the U.S.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…